脳炎治療の世界市場レポート 2025年

脳炎治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.6％で278億5,000万米ドルに成長します。予測期間の成長は、ヘルスケア支出の増加、理学療法の人気の高まり、高齢者人口の増加、脳炎治療の認知度の高まりに起因しています。予測期間の主な動向には、先進的な診断ツール、脳炎の診断と治療におけるaiとml、個別化医薬品の開発、予防脳炎ワクチンの需要、支援ケアなどが含まれます。

脳炎治療市場の成長は、ヘルスケアインフラへの投資の増加によって牽引されると予想されます。ヘルスケア・インフラには、高度な技術を備え、訓練を受けた医療専門家が常駐する病院、診療所、医療研究所など、個人や地域社会への医療提供をサポートする施設、資源、サービスが含まれます。効果的なヘルスケア・インフラは、専門的な医療施設、診断ツール、支援ケアへのアクセスを提供することで、脳炎治療において極めて重要な役割を果たしています。例えば、2023年5月、米国医療協会は、米国の病院数が2021年の6,129から2022年には6,093に増加したと報告しました。さらに、国家統計局の報告によると、英国のヘルスケア支出は2020年から2021年にかけて名目で9.4%、実質で9.7%急増しました。したがって、ヘルスケアインフラ投資の増加動向が脳炎治療市場の成長を後押ししています。

脳炎治療市場の成長が予測される背景には、神経侵襲性疾患の発生率の増加があります。神経侵襲性疾患とは、ウイルスや細菌などの病原体が神経系に侵入し、神経組織の炎症や損傷につながる状態を指します。神経侵襲性疾患の有病率の増加は、脳炎治療に対する需要を生み出し、拡大する患者のニーズに対応するための新しい治療法や医薬品の開発に対する製薬会社や研究者の投資に拍車をかけています。例えば、2023年6月、疾病管理予防センター（CDC）は、2022年7月の6症例に対し、2022年9月には8症例の神経侵襲性ラクロスウイルス人症を報告しました。オハイオ州は報告された総症例数が13例と最も多く、米国の他の地域を上回った。このことは、神経侵襲性疾患の症例数の増加が脳炎治療市場の成長を牽引していることを裏付けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界脳炎治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の脳炎治療市場：成長率分析
• 世界の脳炎治療市場の実績：規模と成長, 2019-2024
• 世界の脳炎治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界脳炎治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の脳炎治療市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 原発性脳炎
• 二次性脳炎
• 世界の脳炎治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ウイルス剤
• ステロイド注射
• 抗生物質
• 免疫グロブリン療法
• 血漿交換
• その他の治療法
• 世界の脳炎治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界の脳炎治療市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像検査
• 血液検査
• 生検
• その他の診断
• 世界の脳炎治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• その他のエンドユーザー
• 世界の脳炎治療市場、原発性脳炎のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウイルス性脳炎
• 細菌性脳炎
• 真菌性脳炎
• 寄生虫性脳炎
• 世界の脳炎治療市場二次性脳炎の分類、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染後脳炎
• 自己免疫性脳炎
• 全身性脳炎

第7章 地域別・国別分析

• 世界の脳炎治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の脳炎治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脳炎治療市場：競合情勢
• 脳炎治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Novartis AG
• Sanofi S.A.
• Bristol Myers Squibb
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries
• Regeneron Pharmaceuticals
• Aurobindo Pharma Limited
• Hikma Pharmaceuticals plc
• Vir Biotechnology
• Torrent Pharmaceuticals Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 脳炎治療市場2029：新たな機会を提供する国
• 脳炎治療市場2029：新たな機会を提供するセグメント
• 脳炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Encephalitis treatment is the treatment of a medical condition characterized by inflammation of the brain, usually caused by a viral infection, a fungal infection, an autoimmune reaction, or certain medications. Encephalitis treatment is used to manage symptoms, slow down the progression of the disease and prevent complications.

Encephalitis can be categorized into two main types are primary encephalitis and secondary encephalitis. Primary encephalitis involves inflammation originating directly within the brain, rather than being a result of an infection originating elsewhere in the body. Treatment for primary encephalitis includes the use of antiviral medications, supportive care, and symptom management. The various treatment approaches are employed, encompassing antiviral agents, steroid injections, antibiotics, immunoglobulin therapy, plasmapheresis, and other treatments. These treatments can be administered via different routes, including oral, parenteral, and other methods. Diagnosing encephalitis involves employing various types of tests such as imaging tests, blood tests, biopsies, and other diagnostic procedures. These diagnostic tests are conducted by healthcare facilities like hospitals, specialty clinics, and others.

The encephalitis treatment market research report is one of a series of new reports from The Business Research Company that provides encephalitis treatment market statistics, including encephalitis treatment industry global market size, regional shares, competitors with an encephalitis treatment market share, detailed encephalitis treatment market segments, market trends and opportunities and any further data you may need to thrive in the encephalitis treatment industry. This encephalitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The encephalitis treatment market size has grown strongly in recent years. It will grow from $21.09 billion in 2024 to $22.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to high incidence of encephalitis, prevalence of viral or bacterial infection, growing government initiatives, rising demand for preventive encephalitis vaccines.

The encephalitis treatment market size is expected to see strong growth in the next few years. It will grow to $27.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to rising healthcare expenditure, increase in the popularity of physical therapy, growing geriatric population, increasing awareness of encephalitis treatment. Major trends in the forecast period include advanced diagnostic tools, ai and ml in encephalitis diagnosis and treatment, development of personalized medicines, demand for preventive encephalitis vaccines, supportive cares.

The growth of the encephalitis treatment market is expected to be driven by increased investments in healthcare infrastructure. Healthcare infrastructure encompasses facilities, resources, and services that support the delivery of medical care to individuals and communities, including hospitals, clinics, and medical laboratories equipped with advanced technology and staffed by trained healthcare professionals. Effective healthcare infrastructure plays a pivotal role in encephalitis treatment by providing access to specialized medical facilities, diagnostic tools, and supportive care. For example, in May 2023, the American Health Care Association reported that the number of hospitals in the US increased from 6,129 in 2021 to 6,093 in 2022. Additionally, healthcare spending in the UK surged by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021, according to a report by the Office for National Statistics. Therefore, the upward trend in healthcare infrastructure investment is propelling the growth of the encephalitis treatment market.

Anticipated growth in the encephalitis treatment market is attributed to the increasing incidence of neuroinvasive diseases. Neuroinvasive diseases refer to conditions where pathogens like viruses or bacteria enter the nervous system, leading to inflammation or damage to nervous tissues. The growing prevalence of neuroinvasive diseases creates a demand for encephalitis treatments, spurring investments by pharmaceutical companies and researchers in the development of new therapies and medications to address the expanding needs of patients. For example, in June 2023, the Centers for Disease Control and Prevention (CDC) reported 8 cases of neuroinvasive La Crosse virus human disease in September 2022, compared to 6 cases in July 2022. Ohio had the highest total cases reported, with 13 cases, surpassing all other regions in the USA. This underscores the driving force of an increasing number of neuroinvasive disease cases on the encephalitis treatment market's growth.

Leading companies in the encephalitis treatment market are concentrating on strategic investments to speed up the development of innovative therapies, boost their research and development efforts, and expand their clinical trial activities. For example, in September 2023, Arialys Therapeutics, a preclinical-stage company based in the US, raised $58 million in seed funding to advance its lead drug candidate, ART5803, which is aimed at treating anti-NMDA receptor encephalitis (ANRE), a common form of autoimmune encephalitis. The company plans to begin clinical trials with healthy volunteers by the end of 2024, followed by trials in ANRE patients in early 2025. Arialys is dedicated to developing targeted therapies that focus on pathogenic antibodies affecting the central nervous system.

In November 2022, Substipharm, a French pharmaceutical company, acquired the IMOJEV Japanese encephalitis vaccine from Sanofi S.A. for an undisclosed amount. This acquisition enhances Substipharm's position in the encephalitis treatment market and complements its geographic expansion efforts. Sanofi S.A. is a French pharmaceutical company known for manufacturing a wide range of medicines and vaccines, including the encephalitis vaccine.

Major companies operating in the encephalitis treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries, Regeneron Pharmaceuticals, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Vir Biotechnology, Torrent Pharmaceuticals Ltd., Valneva SE, Sangamo Therapeutics, Xenon Pharmaceuticals, Tiziana Life Sciences, Vivet Therapeutics, Tetraphase Pharmaceuticals, QED Therapeutics.

North America was the largest region in the encephalitis treatment market in 2024. The regions covered in encephalitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the encephalitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The encephalitis treatment market consists of revenues earned by entities by providing plasmapheresis, immunoglobulin therapy, computed tomography (CT scans), magnetic resonance imaging (MRI) and magnetoencephalography (MEG) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The encephalitis treatment market also includes sales of immunosuppressant drugs, antiseizure medicines and immunomodulators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Encephalitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on encephalitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for encephalitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The encephalitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Primary Encephalitis; Secondary Encephalitis
• 2) By Treatment: Antiviral Agents; Steroid Injections; Antibiotics; Immunoglobulin Therapy; Plasmapheresis; Other Treatments
• 3) By Route of Administration: Oral; Parenteral; Other Routes Of Administrations
• 4) By Diagnosis: Imaging Tests; Blood Tests; Biopsy; Other Diagnosis
• 5) By End-User: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Primary Encephalitis: Viral Encephalitis; Bacterial Encephalitis; Fungal Encephalitis; Parasitic Encephalitis
• 2) By Secondary Encephalitis: Post-Infectious Encephalitis; Autoimmune Encephalitis; Encephalitis Due To Systemic
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Encephalitis Treatment Market Characteristics

3. Encephalitis Treatment Market Trends And Strategies

4. Encephalitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Encephalitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Encephalitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Encephalitis Treatment Market Growth Rate Analysis
• 5.4. Global Encephalitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Encephalitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Encephalitis Treatment Total Addressable Market (TAM)

6. Encephalitis Treatment Market Segmentation

• 6.1. Global Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Encephalitis
• Secondary Encephalitis
• 6.2. Global Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiviral Agents
• Steroid Injections
• Antibiotics
• Immunoglobulin Therapy
• Plasmapheresis
• Other Treatments
• 6.3. Global Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administrations
• 6.4. Global Encephalitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Tests
• Blood Tests
• Biopsy
• Other Diagnosis
• 6.5. Global Encephalitis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users
• 6.6. Global Encephalitis Treatment Market, Sub-Segmentation Of Primary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Encephalitis
• Bacterial Encephalitis
• Fungal Encephalitis
• Parasitic Encephalitis
• 6.7. Global Encephalitis Treatment Market, Sub-Segmentation Of Secondary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Post-Infectious Encephalitis
• Autoimmune Encephalitis
• Encephalitis Due To Systemic

7. Encephalitis Treatment Market Regional And Country Analysis

• 7.1. Global Encephalitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Encephalitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Encephalitis Treatment Market

• 8.1. Asia-Pacific Encephalitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Encephalitis Treatment Market

• 9.1. China Encephalitis Treatment Market Overview
• 9.2. China Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Encephalitis Treatment Market

• 10.1. India Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Encephalitis Treatment Market

• 11.1. Japan Encephalitis Treatment Market Overview
• 11.2. Japan Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Encephalitis Treatment Market

• 12.1. Australia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Encephalitis Treatment Market

• 13.1. Indonesia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Encephalitis Treatment Market

• 14.1. South Korea Encephalitis Treatment Market Overview
• 14.2. South Korea Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Encephalitis Treatment Market

• 15.1. Western Europe Encephalitis Treatment Market Overview
• 15.2. Western Europe Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Encephalitis Treatment Market

• 16.1. UK Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Encephalitis Treatment Market

• 17.1. Germany Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Encephalitis Treatment Market

• 18.1. France Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Encephalitis Treatment Market

• 19.1. Italy Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Encephalitis Treatment Market

• 20.1. Spain Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Encephalitis Treatment Market

• 21.1. Eastern Europe Encephalitis Treatment Market Overview
• 21.2. Eastern Europe Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Encephalitis Treatment Market

• 22.1. Russia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Encephalitis Treatment Market

• 23.1. North America Encephalitis Treatment Market Overview
• 23.2. North America Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Encephalitis Treatment Market

• 24.1. USA Encephalitis Treatment Market Overview
• 24.2. USA Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Encephalitis Treatment Market

• 25.1. Canada Encephalitis Treatment Market Overview
• 25.2. Canada Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Encephalitis Treatment Market

• 26.1. South America Encephalitis Treatment Market Overview
• 26.2. South America Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Encephalitis Treatment Market

• 27.1. Brazil Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Encephalitis Treatment Market

• 28.1. Middle East Encephalitis Treatment Market Overview
• 28.2. Middle East Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Encephalitis Treatment Market

• 29.1. Africa Encephalitis Treatment Market Overview
• 29.2. Africa Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Encephalitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Encephalitis Treatment Market Competitive Landscape
• 30.2. Encephalitis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Encephalitis Treatment Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Novartis AG
• 31.3. Sanofi S.A.
• 31.4. Bristol Myers Squibb
• 31.5. Abbott Laboratories
• 31.6. GlaxoSmithKline plc
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly and Company
• 31.9. Amgen Inc.
• 31.10. Teva Pharmaceutical Industries
• 31.11. Regeneron Pharmaceuticals
• 31.12. Aurobindo Pharma Limited
• 31.13. Hikma Pharmaceuticals plc
• 31.14. Vir Biotechnology
• 31.15. Torrent Pharmaceuticals Ltd.

32. Global Encephalitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Encephalitis Treatment Market

34. Recent Developments In The Encephalitis Treatment Market

35. Encephalitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Encephalitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Encephalitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Encephalitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer